Finally, our data show that Brn-3b is required for survival of SKOV3 ovarian cancer cells because siRNA to reduce Brn-3b can result in loss of cell viability in untreated cells but more importantly, reducing Brn-3b appears to confer increased sensitivity to chemotherapeutic drugs. The gene discussed is POU4F2; the disease is ovarian carcinoma.